Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1595276
[patent_doc_number] => 06384046
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Use of 40-O-(2-hydroxy)ethylrapamycin for treatment of restenosis and other disorders'
[patent_app_type] => B1
[patent_app_number] => 09/712359
[patent_app_country] => US
[patent_app_date] => 2000-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3578
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384046.pdf
[firstpage_image] =>[orig_patent_app_number] => 09712359
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/712359 | Use of 40-O-(2-hydroxy)ethylrapamycin for treatment of restenosis and other disorders | Nov 13, 2000 | Issued |
09/700446 | COMBINATION THERAPY FOR TREATMENT OF BIPOLAR DISORDERS | Nov 8, 2000 | Abandoned |
09/700254 | COMBINATION THERAPY FOR TREATMENT OF REFRACTORY DEPRESSION | Nov 8, 2000 | Abandoned |
09/698511 | Use of aminoguanidine or aminoguanidine analogs for the treatment of diseases of the nervous system | Oct 26, 2000 | Abandoned |
Array
(
[id] => 4331262
[patent_doc_number] => 06313144
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Compositions of optically pure (-) norcisapride'
[patent_app_type] => 1
[patent_app_number] => 9/693945
[patent_app_country] => US
[patent_app_date] => 2000-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8927
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313144.pdf
[firstpage_image] =>[orig_patent_app_number] => 693945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693945 | Compositions of optically pure (-) norcisapride | Oct 22, 2000 | Issued |
Array
(
[id] => 1459995
[patent_doc_number] => 06391876
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Reboxetine for treatment obsessive compulsive disorders and panic disorder'
[patent_app_type] => B1
[patent_app_number] => 09/673768
[patent_app_country] => US
[patent_app_date] => 2000-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1845
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391876.pdf
[firstpage_image] =>[orig_patent_app_number] => 09673768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/673768 | Reboxetine for treatment obsessive compulsive disorders and panic disorder | Oct 18, 2000 | Issued |
09/647909 | Combination therapy for treatment of depression | Oct 5, 2000 | Abandoned |
Array
(
[id] => 7640169
[patent_doc_number] => 06395746
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Methods of treating ophthalmic, otic and nasal infections and attendant inflammation'
[patent_app_type] => B1
[patent_app_number] => 09/646799
[patent_app_country] => US
[patent_app_date] => 2000-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2450
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395746.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646799
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646799 | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation | Sep 21, 2000 | Issued |
Array
(
[id] => 1486827
[patent_doc_number] => 06428787
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'TNF inhibitors for the treatment of retinal disorders'
[patent_app_type] => B1
[patent_app_number] => 09/665529
[patent_app_country] => US
[patent_app_date] => 2000-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6153
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/428/06428787.pdf
[firstpage_image] =>[orig_patent_app_number] => 09665529
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/665529 | TNF inhibitors for the treatment of retinal disorders | Sep 18, 2000 | Issued |
09/664732 | Compositions and methods employing R(-) fluoxetine and other active ingredients | Sep 18, 2000 | Abandoned |
Array
(
[id] => 1551108
[patent_doc_number] => 06399632
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'Method of providing an antihistaminic effect in a hepatically impaired patient'
[patent_app_type] => B1
[patent_app_number] => 09/663343
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2177
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399632.pdf
[firstpage_image] =>[orig_patent_app_number] => 09663343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/663343 | Method of providing an antihistaminic effect in a hepatically impaired patient | Sep 14, 2000 | Issued |
Array
(
[id] => 1565551
[patent_doc_number] => 06339106
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Methods and compositions for the treatment and prevention of sexual dysfunction'
[patent_app_type] => B1
[patent_app_number] => 09/662135
[patent_app_country] => US
[patent_app_date] => 2000-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16334
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/339/06339106.pdf
[firstpage_image] =>[orig_patent_app_number] => 09662135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/662135 | Methods and compositions for the treatment and prevention of sexual dysfunction | Sep 13, 2000 | Issued |
Array
(
[id] => 1596065
[patent_doc_number] => 06492332
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation'
[patent_app_type] => B1
[patent_app_number] => 09/658815
[patent_app_country] => US
[patent_app_date] => 2000-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 38985
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492332.pdf
[firstpage_image] =>[orig_patent_app_number] => 09658815
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/658815 | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation | Sep 10, 2000 | Issued |
Array
(
[id] => 1535110
[patent_doc_number] => 06489349
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Pharmaceutical compositions for inhibition of cytokine production and secretion'
[patent_app_type] => B1
[patent_app_number] => 09/656284
[patent_app_country] => US
[patent_app_date] => 2000-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20570
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489349.pdf
[firstpage_image] =>[orig_patent_app_number] => 09656284
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/656284 | Pharmaceutical compositions for inhibition of cytokine production and secretion | Sep 5, 2000 | Issued |
09/649643 | Methods for preventing pressure induced apoptotic neural cell death | Aug 28, 2000 | Abandoned |
Array
(
[id] => 1490803
[patent_doc_number] => 06417210
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Treatment of dyskinesias and Parkinson\'s disease with riluzole and levodopa'
[patent_app_type] => B1
[patent_app_number] => 09/582989
[patent_app_country] => US
[patent_app_date] => 2000-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2001
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09582989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/582989 | Treatment of dyskinesias and Parkinson's disease with riluzole and levodopa | Aug 27, 2000 | Issued |
Array
(
[id] => 1596076
[patent_doc_number] => 06492334
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Tri-compound analgesic for treating inflammation and pain'
[patent_app_type] => B1
[patent_app_number] => 09/648962
[patent_app_country] => US
[patent_app_date] => 2000-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2123
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492334.pdf
[firstpage_image] =>[orig_patent_app_number] => 09648962
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/648962 | Tri-compound analgesic for treating inflammation and pain | Aug 25, 2000 | Issued |
09/644610 | Paroxetine in treatment of depression | Aug 23, 2000 | Abandoned |
Array
(
[id] => 4322916
[patent_doc_number] => 06331536
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Pharmacological treatment for sleep apnea'
[patent_app_type] => 1
[patent_app_number] => 9/622823
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9578
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331536.pdf
[firstpage_image] =>[orig_patent_app_number] => 622823
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/622823 | Pharmacological treatment for sleep apnea | Aug 22, 2000 | Issued |
Array
(
[id] => 4305873
[patent_doc_number] => 06326404
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Use of O-desmethyl-N-mono-desmethyl-tramadol'
[patent_app_type] => 1
[patent_app_number] => 9/642152
[patent_app_country] => US
[patent_app_date] => 2000-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2614
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326404.pdf
[firstpage_image] =>[orig_patent_app_number] => 642152
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/642152 | Use of O-desmethyl-N-mono-desmethyl-tramadol | Aug 20, 2000 | Issued |